Tower Research Capital (TRC)’s PolyPid PYPD Stock Holding History
Bought
Maintained
Sold
Other funds holding PYPD
RJFSA
JWM
XS
BFM
Tower Research Capital (TRC)'s PYPD Position: Q3 2022 in Review
Tower Research Capital (TRC) sold out of PolyPid (PYPD) in Q3 2022, closing a stake of 72 shares — an estimated $10K sold.
Tower Research Capital (TRC) first reported a position in PYPD in Q4 2020 and held it in 5 quarters. The position peaked at $22K in Q1 2021. 17 funds tracked by Wall St. Rank hold PYPD as of Q3 2022.
- Tower Research Capital (TRC) reported no remaining PolyPid position as of Q3 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 72 PolyPid shares in Q3 2022, an estimated $10K.
- Tower Research Capital (TRC) first reported a position in PolyPid in Q4 2020 and held it in 5 quarters.
- Tower Research Capital (TRC)'s PolyPid position peaked at $22K in Q1 2021.
- 17 funds tracked by Wall St. Rank held PolyPid as of Q3 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.